Records containing: Liver Cirrhosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-25Serosurvey of HAV Immunity and Single-dose Vaccine Immunogenicity Among Patients With Cirrhosis.
-
CLINICAL_TRIALS study record update · 2026-02-24Study of the Validity of Intensive Care Cirrhosis Outcome Score (ICCO) in Predicting Outcome in Cirrhotic Patients Admitted to Intensive Care Unit.
-
CLINICAL_TRIALS study record update · 2026-02-24PROMISE Trial: A PROspective Randomised Double-blind Parallel Group Placebo-controlled Multicentre Trial of Faecal MIcrobiota tranSplantation to Improve the Primary outcomE (First Hospitalisation Due to Infection) in Patients With Cirrhosis Over 24 Months
-
CLINICAL_TRIALS study record update · 2026-02-20Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation
-
CLINICAL_TRIALS study record update · 2026-02-20The Effect of the Use of ReLiver-N App Developed for Patients With Liver Cirrhosis on Hepatic Rehabilitation: A Randomized Controlled Single-Blind Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-18Development and Psychometric Validation of The Liver Cirrhosis Cognitive Decline Scale (LiCCoS)
-
CLINICAL_TRIALS study record update · 2026-02-09Dose Prediction for Antihypertensive Medications in Cirrhotic Patients Using Simcyp Program: Applications in Clinical Practice
-
CLINICAL_TRIALS study record update · 2026-01-29Improving Healthcare Outcomes With Early Detection of Liver Related Complications in Liver Cirrhosis Patients by Implementing a Telemedicine Care Pathway (myLIVERcoach): a Multicenter Feasibility Study
-
CLINICAL_TRIALS study record update · 2026-01-29A Multicentre, Observational Study in Patients With Liver Cirrhosis Who Have Hepatic Decompensation (OPAL)
-
CLINICAL_TRIALS study record update · 2026-01-28A New Regenerative Medicine Protocol Using Autologous Bone Marrow Mononuclear Cells With Growth Factors to Treat Liver Cirrhosis
-
CLINICAL_TRIALS study record update · 2026-01-22A Phase I, Open-label Trial on the Safety and Efficacy of Human Umbilical Cord-derived Mesenchymal Stem Cell Administration in the Management of Adult Liver Cirrhosis
-
CLINICAL_TRIALS study record update · 2026-01-20TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for the Treatment of Unresectable Hepatocellular Carcinoma With Cirrhotic Portal Hypertension: A Multicenter, Simon Two-Stage, Single-Arm Study
-
CLINICAL_TRIALS study record update · 2026-01-20Underdilated-stent Technique Improves Post-transjugular Intrahepatic Portosystemic Shunt Encephalopathy: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-01-20Effect of High Flow Nasal Cannula Oxygenation on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients: A Multicentre Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-01-20A Multicentre, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Combination Compared to Zibotentan Monotherapy, Zibotentan/Dapagliflozin and Zibotentan Monotherapy Compared to Placebo in Participants With Cirrhosis
-
CLINICAL_TRIALS study record update · 2026-01-14naVIGation Invitations Liver surveillANce upTake
-
CLINICAL_TRIALS study record update · 2026-01-13Transporter Profiling Study for P-glycoprotein 1 (P-gp), Organic Anion Transporter 1 (OAT1), Organic Anion Transporter 3 (OAT3), Organic Cation Transporter 2 (OCT2), Multidrug and Toxin Extrusion Protein 1 (MATE1), Multidrug and Toxin Extrusion Protein 2-K (MATE2-K), Organic Anion Transporting Polypeptide 1B1 (OATP1B1), Organic Anion Transporting Polypeptide 1B3 (OATP1B3) and Breast Cancer Resistance Protein (BCRP) in Healthy Subjects and in Patients With Stage 4 (F4) Liver Fibrosis / Cirrhosis.
-
CLINICAL_TRIALS study record update · 2026-01-13Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis
-
CLINICAL_TRIALS study record update · 2026-01-08An Observational Explorative Study to Determine Pharmacokinetic Changes of Ceftriaxone in Blood and Ascites in Patients Admitted With Decompensated Liver Cirrhosis With or Without Renal Impairment.
-
CLINICAL_TRIALS study record update · 2026-01-05EUS-guided Versus Percutaneous Ultrasound-guided Biopsy for Parenchymal Liver Disease: A Randomized Controlled, Non-inferiority Trial
-
CLINICAL_TRIALS study record update · 2025-12-30Verification of Prognostic Risk Factors of Thrombohemorrhagic Complications in Early Follow-up Period in Recipients After Living Related Liver Transplantation
-
CLINICAL_TRIALS study record update · 2025-12-23Characterization of Focal Liver Lesions by Real-time Contrast-enhanced Ultrasound Imaging (CEUS)
-
CLINICAL_TRIALS study record update · 2025-12-22Long Term Follow up Autologous Mesenchymal Stem Cell Therapy for Patients Virus-related Liver Cirrhosis
-
CLINICAL_TRIALS study record update · 2025-12-16Impact of Repurposed Growth Hormone Treatment on Clinical, Nutritional, Immunological and Regenerative Parameters in Decompensated Liver Cirrhosis: a Randomized Control Trial
-
CLINICAL_TRIALS study record update · 2025-12-09Research on the Role of Phycocyanin in the Prevention, Treatment, and Mechanism of Liver Fibrosis/Cirrhosis